Clinical Coagulation, Malmö
31 – 40 of 659
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Historical perspective on von Willebrand disease
(2024) p.1-6
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Textbook of von Willebrand Disease : Basic and Clinical Aspects
- Book/Report › Anthology (editor)
-
Mark
Low bleeding rates after intramuscular Covid-19 vaccination in patients with haemophilia and von Willebrand disease : Outcome data from the Swedish haemophilia registry
- Contribution to journal › Debate/Note/Editorial
-
Mark
Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8) : a prospective, multicentre, open-label, randomised, phase 3a trial
- Contribution to journal › Article
- 2023
-
Mark
Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia : A review of the literature
- Contribution to journal › Scientific review
-
Mark
Clinical, economic, and health-related quality of life burden associated with von Willebrand disease in adults and children : Systematic and targeted literature reviews
- Contribution to journal › Scientific review
-
Mark
No difference in quality of life between persons with severe haemophilia A and B
- Contribution to journal › Article
-
Mark
Incidental pulmonary embolism in patients with cancer : prevalence, underdiagnosis and evaluation of an AI algorithm for automatic detection of pulmonary embolism
- Contribution to journal › Article
-
Mark
Area under the curve : Comparing the value of factor VIII replacement therapies in haemophilia A
- Contribution to journal › Article
-
Mark
Real-world prophylactic usage of recombinant factor IX Fc in Sweden : A report from the Swedish National Registry for bleeding disorders
- Contribution to journal › Letter
